loading
前日終値:
$4.36
開ける:
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額:
$96.26M
収益:
-
当期純損益:
$-94.11M
株価収益率:
0.00
EPS:
-6.01
ネットキャッシュフロー:
$-86.06M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
Value
$0.00
$0.00
1週間の範囲:
Value
$0.00
$0.00
52週間の値動き範囲:
Value
$0.00
$5.75

Adverum Biotechnologies Inc Stock (ADVM) Company Profile

Name
名前
Adverum Biotechnologies Inc
Name
セクター
Healthcare (1117)
Name
電話
(650) 649-1004
Name
住所
100 CARDINAL WAY, REDWOOD CITY, CA
Name
職員
155
Name
Twitter
@adverumbio
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ADVM's Discussions on Twitter

ADVM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ADVM
Adverum Biotechnologies Inc
0.00 96.26M 0 -94.11M -86.06M -6.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
473.39 119.17B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
808.90 84.19B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
408.56 52.77B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
812.83 48.98B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
176.28 36.31B 447.02M -1.18B -906.14M -6.1812

Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-17 ダウングレード H.C. Wainwright Buy → Neutral
2024-06-25 開始されました Oppenheimer Outperform
2024-04-30 開始されました H.C. Wainwright Buy
2022-07-07 アップグレード Truist Hold → Buy
2021-07-23 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-05-03 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-04-29 ダウングレード Chardan Capital Markets Buy → Neutral
2021-04-29 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2021-04-29 ダウングレード Truist Buy → Hold
2020-12-16 開始されました UBS Neutral
2020-11-12 アップグレード Raymond James Underperform → Mkt Perform
2020-06-26 ダウングレード Raymond James Mkt Perform → Underperform
2020-05-13 開始されました RBC Capital Mkts Outperform
2020-05-05 アップグレード SunTrust Hold → Buy
2020-04-28 開始されました Goldman Buy
2020-03-16 開始されました SVB Leerink Outperform
2020-02-10 アップグレード Cantor Fitzgerald Neutral → Overweight
2020-02-10 アップグレード Chardan Capital Markets Neutral → Buy
2019-10-15 繰り返されました Chardan Capital Markets Neutral
2019-09-13 繰り返されました Chardan Capital Markets Neutral
2019-06-14 再開されました Raymond James Mkt Perform
2018-11-02 ダウングレード Raymond James Outperform → Mkt Perform
2018-11-02 ダウングレード SunTrust Buy → Hold
2018-09-21 開始されました Cantor Fitzgerald Overweight
2018-08-30 開始されました SunTrust Buy
2018-02-15 再開されました Piper Jaffray Overweight
2017-10-12 開始されました Raymond James Outperform
すべてを表示

Adverum Biotechnologies Inc (ADVM) 最新ニュース

pulisher
Jan 08, 2026

Is Adverum Biotechnologies Inc. stock a dividend growth opportunityJuly 2025 Update & Long-Term Capital Growth Ideas - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How Adverum Biotechnologies Inc. stock benefits from strong dollarPortfolio Return Report & Real-Time Stock Entry Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why hedge funds are buying Adverum Biotechnologies Inc. stockJuly 2025 Closing Moves & Weekly Sector Rotation Insights - ulpravda.ru

Jan 08, 2026
pulisher
Jan 05, 2026

What drives Adverum Biotechnologies Inc stock priceValue Stock Picks & Capital Planning and Optimization - earlytimes.in

Jan 05, 2026
pulisher
Jan 03, 2026

ADVM stock touches 52-week low at $4.01 amid market challenges - MSN

Jan 03, 2026
pulisher
Dec 31, 2025

Adverum Biotechnologies, Inc. Financial Disclosures & Filings - TradingView — Track All Markets

Dec 31, 2025
pulisher
Dec 25, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Stock Price Passes Above 50 Day Moving Average – Time to Sell? - Defense World

Dec 25, 2025
pulisher
Dec 20, 2025

Is Adverum Biotechnologies Inc. (AVU0) stock trading at attractive multiplesJuly 2025 Catalysts & Short-Term High Return Ideas - Bölüm Sonu Canavarı

Dec 20, 2025
pulisher
Dec 20, 2025

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives $10.50 Average PT from Brokerages - Defense World

Dec 20, 2025
pulisher
Dec 20, 2025

What catalysts could drive Adverum Biotechnologies Inc. stock higherJuly 2025 Chart Watch & Fast Momentum Entry Tips - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Why Adverum Biotechnologies Inc. stock is rated strong buyWeekly Trend Report & Free Long-Term Investment Growth Plans - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Why Adverum Biotechnologies Inc. stock is in analyst buy zoneJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - DonanımHaber

Dec 19, 2025
pulisher
Dec 17, 2025

Investor Mood: Why Adverum Biotechnologies Inc stock is in analyst buy zoneJuly 2025 Review & Precise Swing Trade Entry Alerts - moha.gov.vn

Dec 17, 2025
pulisher
Dec 16, 2025

Adverum Biotechnologies releases promising phase 2 trial data - MSN

Dec 16, 2025
pulisher
Dec 15, 2025

Adverum Biotechnologies Earnings Notes - Trefis

Dec 15, 2025
pulisher
Dec 13, 2025

Adverum Biotechnologies, Inc. Stock ()Quote BOERSE BERLIN - marketscreener.com

Dec 13, 2025
pulisher
Dec 13, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Lowered to "Strong Sell" Rating by Wall Street Zen - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Lowered to “Strong Sell” Rating by Wall Street Zen - Defense World

Dec 13, 2025
pulisher
Dec 12, 2025

Market Catalysts: Why hedge funds are buying Adverum Biotechnologies Inc stockJuly 2025 Spike Watch & Consistent Return Investment Signals - moha.gov.vn

Dec 12, 2025
pulisher
Dec 12, 2025

Hedge Fund and Insider Trading News: Cathie Wood, Michael Burry, Renaissance Technologies, Mason Capital, Millennium Management, Adverum Biotechnologies Inc (ADVM), MGM Resorts International (MGM), and More - Insider Monkey

Dec 12, 2025
pulisher
Dec 11, 2025

Adverum Biotechnologies, Inc.(NasdaqCM: ADVM) dropped from S&P TMI Index - marketscreener.com

Dec 11, 2025
pulisher
Dec 11, 2025

Eli Lilly completes acquisition of Adverum Biotechnologies - MSN

Dec 11, 2025
pulisher
Dec 10, 2025

CEO Fischer Acquires 650,000 Of Adverum Biotechnologies Inc [ADVM] - TradingView — Track All Markets

Dec 10, 2025
pulisher
Dec 10, 2025

Lilly moves forward with $3.56-per-share acquisition of Adverum - Indian Pharma Post

Dec 10, 2025
pulisher
Dec 10, 2025

Lilly completes tender offer for Adverum Biotechnologies By Investing.com - Investing.com Australia

Dec 10, 2025
pulisher
Dec 10, 2025

Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition - The AI Journal

Dec 10, 2025
pulisher
Dec 09, 2025

Lilly completes tender offer for Adverum Biotechnologies - Investing.com India

Dec 09, 2025
pulisher
Dec 09, 2025

Eli Lilly (LLY) Stock on December 9, 2025: Jaypirca Breakthrough, Adverum Deal and Zepbound Price Cuts Reframe the Outlook - ts2.tech

Dec 09, 2025
pulisher
Dec 09, 2025

Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies - GuruFocus

Dec 09, 2025
pulisher
Dec 09, 2025

Eli Lilly Moves Forward With Acquisition Of Adverum Biotechnologies - Nasdaq

Dec 09, 2025
pulisher
Dec 09, 2025

Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops - Investing.com Australia

Dec 09, 2025
pulisher
Dec 09, 2025

Adverum Biotechnologies Stock (ADVM) Opinions on Lilly Acquisition - Quiver Quantitative

Dec 09, 2025
pulisher
Dec 09, 2025

Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition | Eli Lilly and Company - Eli Lilly

Dec 09, 2025
pulisher
Dec 09, 2025

Lilly completes Adverum acquisition for $3.56 per share plus CVRs - StreetInsider

Dec 09, 2025
pulisher
Dec 08, 2025

Laurent Fischer Acquires 117,614 Shares of Adverum Biotechnologies (NASDAQ:ADVM) Stock - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Insider Buying: Laurent Fischer Acquires Shares of Adverum Biote - GuruFocus

Dec 08, 2025
pulisher
Dec 08, 2025

Soparkar Peter, Adverum Biotechnologies COO, buys $211k in shares By Investing.com - Investing.com Canada

Dec 08, 2025
pulisher
Dec 08, 2025

Adverum biotechnologies CEO Fischer buys shares worth $553916 By Investing.com - Investing.com Canada

Dec 08, 2025
pulisher
Dec 08, 2025

Adverum Biotechnologies Executives Increase Stake in Company - TradingView — Track All Markets

Dec 08, 2025
pulisher
Dec 08, 2025

CEO Fischer Buys 128,699 ($553.9K) Of Adverum Biotechnologies Inc [ADVM] - TradingView — Track All Markets

Dec 08, 2025
pulisher
Dec 08, 2025

Adverum Biotechnologies, Inc.(NasdaqGM: ADVM) dropped from NASDAQ Composite Index - marketscreener.com

Dec 08, 2025
pulisher
Dec 08, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $2,197,906.40 in Stock - Defense World

Dec 08, 2025
pulisher
Dec 08, 2025

null - Trefis

Dec 08, 2025
pulisher
Dec 07, 2025

Adverum Biotechnologies, Inc.(NasdaqCM: ADVM) dropped from Russell Microcap Index - marketscreener.com

Dec 07, 2025
pulisher
Dec 07, 2025

Adverum Biotechnologies, Inc.(NasdaqCM:ADVM) dropped from Russell Microcap Value Index - marketscreener.com

Dec 07, 2025
pulisher
Dec 06, 2025

Insider Selling: Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $2,197,906.40 in Stock - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

What analysts say about Adverum Biotechnologies Inc stockEarnings Per Share Trends & Try Our Free Strategy Builder Now - earlytimes.in

Dec 06, 2025
pulisher
Dec 05, 2025

Owner Leonard Sells 524,560 ($2.2M) Of Adverum Biotechnologies Inc [ADVM] - TradingView

Dec 05, 2025
pulisher
Dec 05, 2025

Adverum Reminds Stockholders to Tender Their Shares Into the Offer by Lilly - 富途牛牛

Dec 05, 2025
pulisher
Dec 05, 2025

LUNA Surges 20% in a Day Amid Ongoing Terra Network Upgrade - Bitget

Dec 05, 2025
pulisher
Dec 05, 2025

Why retail traders accumulate Adverum Biotechnologies Inc. (AVU0) stockWeekly Profit Report & Advanced Swing Trade Entry Alerts - Newser

Dec 05, 2025

Adverum Biotechnologies Inc (ADVM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$33.71
price up icon 0.10%
$106.77
price up icon 0.59%
$116.62
price up icon 8.60%
$99.59
price up icon 0.55%
biotechnology ONC
$331.62
price up icon 2.72%
$183.80
price up icon 7.25%
大文字化:     |  ボリューム (24 時間):